Japanese Life Sciences Stock News

TSE:4307
TSE:4307IT

Nomura Research Institute (TSE:4307) Q4 EPS Loss Challenges Bullish Margin Recovery Narratives

Latest FY 2026 Results Snapshot Nomura Research Institute (TSE:4307) has just capped FY 2026 with fourth quarter revenue of ¥212.4b and a basic EPS loss of ¥118.43, a sharp contrast to the trailing twelve month EPS of ¥26.62 and net income of ¥15.3b. Over the past several quarters, revenue has moved from ¥196.6b in Q4 FY 2025 to ¥195.8b, ¥201.3b and ¥205.3b, before reaching ¥212.4b in Q4 FY 2026. Quarterly basic EPS shifted from ¥38.40 to ¥45.43, ¥48.09 and ¥51.68, ahead of the latest...
TSE:6954
TSE:6954Machinery

Fanuc (TSE:6954) Margin Strength And 12.9% Earnings Growth Test Valuation Concerns

Fanuc (TSE:6954) closed out FY 2026 with fourth quarter revenue of ¥234.5b and basic EPS of ¥53.24, set against trailing 12 month revenue of ¥857.8b and EPS of ¥178.47. Earnings over the past year improved 12.9% with forecasts pointing to about 7.4% annual growth. Over recent periods the company has seen quarterly revenue move from ¥197.1b in FY 2025 Q3 to ¥234.5b in FY 2026 Q4, with basic EPS over those same quarters ranging from ¥35.21 to ¥53.24. Trailing net margin held at 19.4% versus...
TSE:6723
TSE:6723Semiconductor

Renesas Electronics (TSE:6723) Q1 Profit Rebound Tests Bearish Unprofitability Narrative

Renesas Electronics (TSE:6723) opened Q1 2026 with revenue of ¥380.3 billion and basic EPS of ¥37.57, while trailing twelve month EPS sits at a loss of ¥5.31, underlining that the latest quarterly profit is set against a still-unprofitable year. The company has seen quarterly revenue move from ¥292.6 billion in Q4 2024 to ¥380.3 billion in Q1 2026, with basic EPS ranging from a loss of ¥33.38 in Q2 2025 to ¥58.66 in Q3 2025. Investors are watching how consistently these margins can hold up...
TSE:8604
TSE:8604Capital Markets

Nomura Holdings (TSE:8604) Margin Slippage Tests Long Running Earnings Growth Narrative

Nomura Holdings (TSE:8604) has wrapped up FY 2026 with fourth quarter revenue of ¥577.2b and basic EPS of ¥25.29, setting the tone for how investors assess the latest earnings run. Over recent periods, revenue has moved from ¥452.7b in FY 2025 Q4 to ¥577.2b in FY 2026 Q4, while quarterly basic EPS shifted from ¥24.35 to ¥25.29. On a trailing twelve month basis, EPS and net income reached ¥123.08 and ¥362.1b respectively, supported by revenue of ¥2.17t. With a trailing net margin of 16.7%...
TSE:5423
TSE:5423Metals and Mining

Tokyo Steel Manufacturing (TSE:5423) Margin Decline Reinforces Bearish Narratives On Earnings Quality

Tokyo Steel Manufacturing (TSE:5423) has wrapped up FY 2026 with fourth quarter revenue of ¥66.2b and basic EPS of ¥21.05, setting the tone for a year where trailing twelve month revenue came in at ¥268.1b and EPS at ¥112.55. Over recent periods the company has seen quarterly revenue move from ¥80.4b and EPS of ¥66.02 in FY 2025 Q3 to ¥73.1b and EPS of ¥36.18 in FY 2026 Q1, before settling at FY 2026 Q4 levels. This frames a year where investors are likely to focus on how thinner margins and...
TSE:4519
TSE:4519Pharmaceuticals

Chugai Pharmaceutical (TSE:4519) Q1 Net Margin Near 35% Reinforces Bullish Profitability Narratives

Chugai Pharmaceutical (TSE:4519) opened 2026 with Q1 revenue of ¥321,747 million and basic EPS of ¥70.13, setting the tone off the back of a year where trailing twelve month revenue reached about ¥1.29 trillion and EPS came in at ¥274.77. Over recent quarters the company has seen revenue move from ¥288,459 million and EPS of ¥59.09 in Q1 2025 to ¥346,301 million and EPS of ¥78.04 in Q4 2025, giving you a clear view of the top line and per share earnings trend heading into the latest print...
TSE:1605
TSE:1605Oil and Gas

A Look At Inpex’s (TSE:1605) Valuation After Recent Share Price Pullback And Strong 1 Year Return

Recent performance snapshot Inpex (TSE:1605) has drawn attention after a 2.6% gain over the past day and 2.2% over the past week, in contrast with an 8.3% decline over the past month but a 26.1% rise over the past 3 months. See our latest analysis for Inpex. The recent pullback, including a 1 month share price return of negative 8.3%, sits against a stronger backdrop. A 3 month share price return of 26.1% and a 1 year total shareholder return above 100% suggest that momentum has been building...
TSE:2502
TSE:2502Beverage

A Look At Asahi Group Holdings (TSE:2502) Valuation After Recent Mixed Share Returns

Recent returns and business snapshot Asahi Group Holdings (TSE:2502) has recently drawn attention after a stretch of mixed share returns, including a 0.6% decline in the latest session and weaker performance over the past year. The company operates a broad beverage and food portfolio across Japan, Europe, Oceania, and Southeast Asia, generating revenue of ¥2,926,294 and net income of ¥155,563, with annual revenue growth of 3.9% and net income growth of 10.3%. See our latest analysis for Asahi...
TSE:8031
TSE:8031Trade Distributors

Is It Too Late To Consider Mitsui (TSE:8031) After A 110% One Year Surge?

If you are wondering whether Mitsui's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current numbers say. Mitsui recently closed at ¥5,784, with a 1-year return of 110.0%, a 3-year return of 197.3% and a very large 5-year gain. However, the stock has seen a 0.3% decline over 7 days and a 7.5% decline over 30 days, while the year-to-date return stands at 21.7%. Recent coverage has focused on Mitsui's...
TSE:3407
TSE:3407Chemicals

Asahi Kasei Expands Pharma Reach With Aicuris Deal And AK1940 Trial

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...
TSE:7912
TSE:7912Commercial Services

How Investors May Respond To Dai Nippon Printing (TSE:7912) Expanding Its Advanced Automotive Display Films

Dai Nippon Printing Co., Ltd. has announced it will begin mass production in April 2026 of a new decorative film for automotive displays that combines woodgrain-style design with advanced optical performance, initially targeting the Chinese market before moving into Europe, Japan, the United States, South Korea, India and other regions. An interesting angle is DNP’s plan to apply this microfabricated, Electron Beam-coated film beyond car interiors, including exterior auto components and...
TSE:7974
TSE:7974Entertainment

Nintendo (TSE:7974) Is Down 7.5% After Cutting Switch 2 Output Amid Rising Memory Costs – What's Changed

Nintendo recently reported rising memory component costs that it cannot pass on to customers, pressuring margins and forcing a cut in quarterly Switch 2 production from 6 million to 4 million units amid softer demand. An interesting angle is that, despite these operational headwinds, the company is leaning on its sizeable cash reserves to support its longer-term business plans. We’ll now explore how rising memory costs and reduced Switch 2 production are shaping Nintendo’s investment...
TSE:8015
TSE:8015Trade Distributors

Is It Too Late To Consider Toyota Tsusho (TSE:8015) After Its 143% One Year Surge?

If you are wondering whether Toyota Tsusho at ¥6,100 still offers value, the key is understanding how its current price lines up with different valuation checks. The stock is up 10.8% year to date, with a 142.7% return over the past year, even though the last 7 and 30 days show modest declines of 2.3% and 2.1%. Recent coverage has focused on Toyota Tsusho as part of broader discussions around major Japanese trading houses and their roles in global supply chains, resource sourcing, and...
TSE:2268
TSE:2268Hospitality

B R 31 Ice CreamLtd Q4 EPS Loss Tests Bullish High Quality Earnings Narrative

B-R 31 Ice CreamLtd (TSE:2268) has opened Q1 2026 earnings season with recent quarterly revenue of ¥8,432 million in Q4 2025 and a basic EPS loss of ¥22.62, set against trailing twelve month EPS of ¥183.69 on revenue of ¥34.29 billion that grew from ¥30.69 billion a year earlier. The company has seen revenue move from ¥29,088 million in Q3 2024 to ¥34,285 million in the latest trailing twelve month reading, while quarterly EPS has ranged from ¥75.03 in Q3 2024 to ¥93.09 in Q3 2025, giving...
TSE:5344
TSE:5344Electronic

High Growth Tech Stocks to Watch in April 2026

In April 2026, global markets are experiencing strong upward momentum, fueled by de-escalating geopolitical tensions in the Middle East and positive economic indicators from major regions like the U.S. and China. As key indices such as the Nasdaq Composite and Russell 2000 reach record highs, investors are increasingly focused on high-growth tech stocks that demonstrate robust earnings potential and innovation-driven growth, making them attractive in this buoyant market environment.
TSE:7751
TSE:7751Tech

Canon (TSE:7751) Q4 Margin Rebound Challenges Cautious Earnings Narratives

Canon (TSE:7751) opened 2026 by extending its recent momentum, with Q4 2025 revenue at ¥1.32t and basic EPS of ¥124.48, wrapping up a trailing twelve month EPS of ¥367.48 and revenue of ¥4.62t alongside earnings growth of 107.5% over the past year. The company has seen quarterly revenue move from ¥1.06t in Q1 2025 to ¥1.10t in Q3 and ¥1.32t in Q4, while basic EPS shifted from ¥77.27 to ¥71.51 and then ¥124.48 over the same stretch, underpinned by a trailing net profit margin of 7.2% versus...